Company / Inventory per Share
Myriad Genetics, Inc. Inventory per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory per Share
$0.38
FY2025
5-year range
$0.22 / $0.38
FY2021-FY2025
Trend
+9.6%
vs FY2024
Sector context
#67 of 105
Health Care
What the data says
At $0.38, Myriad Genetics, Inc.'s inventory per share ranks #67 of 105 in the Health Care sector. Inventory per Share has increased for 4 consecutive years, from $0.22 in FY2021 to $0.38 in FY2025.
Based on SEC 10-K filings.
0.38 in FY2025 with a 5-year CAGR of -1.0%.
Improved from $0.29 to $0.38 over the past 2 years.
Health Care sector context is included.
Inventory per Share over time
Growth rates
- 3-Year CAGR
- +11.3%
- 5-Year CAGR
- -1.0%
- 10-Year CAGR
- -
Sector benchmark
#67 of 105 in Health CareTop 64% of 105This company $0.38 Sector average $30.82
▼
-98.8% below sector average
Key checks
Key Insights
- Myriad Genetics, Inc.'s inventory per share has grown for 4 consecutive years.
- In FY2025, inventory per share increased 9.6% year-over-year.
- Ranks #67 out of 105 companies in the Health Care sector.
- Peak inventory per share was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score -1.23 (distress zone, below 1.8 threshold)
- Negative profit margin: -15.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Inventory per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.38 | +9.6% |
| FY2024 | $0.34 | +17.8% |
| FY2023 | $0.29 | +6.7% |
| FY2022 | $0.27 | +26.2% |
| FY2021 | $0.22 | -45.3% |
| FY2020 | $0.40 | -12.8% |
| FY2019 | $0.45 | -8.7% |
| FY2018 | $0.50 | -13.3% |
| FY2017 | $0.57 | +20.8% |
| FY2016 | $0.48 | +56.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026